Appeals Court Refuses To Rehear ‘Skinny Label’ Case

By John Wilkerson / February 24, 2022 at 1:39 PM
A federal appeals court in Delaware refused to rehear a lawsuit over so-called skinny labels, and generic drug makers say the ruling will delay generic competition. Teva reportedly plans to appeal the case to the U.S. Supreme Court, but the company didn’t not respond to requests for confirmation. The lawsuit (case no.: 2018cvpri1976) is over Teva’s generic of the GlaxoSmithKline heart drug Coreg. Teva asked for a rehearing after the court ruled that Teva improperly promoted its generic Coreg, approved...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.